<?xml version="1.0" encoding="UTF-8"?>
<p>Analysis of IgG subclasses revealed that DOPS suppressed IgG1 responses and enhanced IgG2a and IgG2b responses, corroborating results obtained with a previous vaccine formulations against Malaria [
 <xref rid="B36-vaccines-07-00072" ref-type="bibr">36</xref>]. In contrast, EDIII alone only induced IgG1 but failed to generate IgG2a and IgG2b responses. CuMVtt-EDIII induced an intermediate response, and all three IgG subclasses were generated (
 <xref ref-type="fig" rid="vaccines-07-00072-f003">Figure 3</xref>).
</p>
